Welcome to LookChem.com Sign In|Join Free

CAS

  • or

115527-12-3

(20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

115527-12-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 115527-12-3 Structure

  • Basic information

    1. Product Name: (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al
    2. Synonyms: (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al
    3. CAS NO:115527-12-3
    4. Molecular Formula:
    5. Molecular Weight: 314.425
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 115527-12-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al(CAS DataBase Reference)
    10. NIST Chemistry Reference: (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al(115527-12-3)
    11. EPA Substance Registry System: (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholan-22-al(115527-12-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 115527-12-3(Hazardous Substances Data)

115527-12-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 115527-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,5,2 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 115527-12:
(8*1)+(7*1)+(6*5)+(5*5)+(4*2)+(3*7)+(2*1)+(1*2)=103
103 % 10 = 3
So 115527-12-3 is a valid CAS Registry Number.

115527-12-3Relevant articles and documents

2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses

-

Page/Page column 8, (2012/11/13)

This invention discloses 2α-methyl and 2β-methyl analogs of 19,26-dinor-1α,25-dihydroxyvitamin D3 and pharmaceutical uses therefor. These compounds exhibit in vitro biological activities evidencing use as an anti-cancer agent and for the treatm

(20S,22E)-2-METHYLENE-19-NOR-22-ENE-1&α,25-DIHYDROXYVITAMIN D3 ANALOGS

-

Page/Page column 12-13, (2011/04/25)

This invention discloses (20S.22E)-2-mcthylenc-19-nor-22-enc-1α,25- dihydroxyvitamin D3 analogs, and specifically(20S,22E)-2 -methylene- 19-nor-22-ene- 1 α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhib

2-METHYLENE-19,26-NOR-(20S)-1α-HYDROXYVITAMIN D3

-

, (2011/06/23)

Compounds of formula I are provided where X1 and X2 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biologica

Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D3 markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription

Grzywacz, Pawel,Chiellini, Grazia,Plum, Lori A.,Clagett-Dame, Margaret,Deluca, Hector F.

experimental part, p. 8642 - 8649 (2011/03/20)

Twelve new analogues of 19-nor-1α,25-dihydroxyvitamin D3 (5-16) were prepared by convergent syntheses, employing the Wittig Horner reaction. The necessary Grundmann type ketones (45-48), possessing fixed configurations of the hydroxyl group at

2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs

-

Page/Page column 5-7, (2010/02/17)

This invention discloses 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs, and specifically 2-methylene-19,26-dinor-(20S,22E,25R)-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits transcription activity

2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs

-

Page/Page column 5-6; 8, (2009/07/17)

This invention discloses 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs, and specifically 2-methylene-(20S,25R)-19,26-dinor-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits pronounced activity in arrestin

2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs

-

Page/Page column 5-6; 8, (2009/07/17)

This invention discloses 2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs, and specifically 2-methylene-(20S,25S)-19,26-dinor-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits pronounced activity in arrestin

2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs

-

Page/Page column 5-6; 7, (2008/06/13)

This invention discloses 2-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogs, and specifically 2-methylene-(20S,25S)-19,27-dinor-(22E)-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits pronounced activity

2-alkylidene-18,19-dinor-vitamin D compounds

-

Page/Page column 7-8, (2010/02/14)

2-alkylidene-18,19-dinor-vitamin D compounds are disclosed as well as pharmaceutical uses for these compounds and methods of synthesizing these compounds. These compounds are characterized by low bone calcium mobilization activity and high intestinal calc

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 115527-12-3